These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 2962686

  • 1. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B, Domeney AM, Naylor RJ, Tyers MB.
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [Abstract] [Full Text] [Related]

  • 2. Desenkephalin-gamma-endorphin is an antagonist of the hyperactivity response induced by infusion of dopamine into the nucleus accumbens of rat and ventral striatum of marmoset.
    Costall B, Domeney AM, Naylor RJ.
    Neuropharmacology; 1989 Nov; 28(11):1223-9. PubMed ID: 2574424
    [Abstract] [Full Text] [Related]

  • 3. The psychopharmacology of 5-HT3 receptors.
    Costall B, Naylor RJ, Tyers MB.
    Pharmacol Ther; 1990 Nov; 47(2):181-202. PubMed ID: 2203069
    [Abstract] [Full Text] [Related]

  • 4. Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding.
    Koulu M, Lappalainen J, Hietala J, Sjöholm B.
    Psychopharmacology (Berl); 1990 Nov; 101(2):168-71. PubMed ID: 2140903
    [Abstract] [Full Text] [Related]

  • 5. Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat.
    Hagan RM, Jones BJ, Jordan CC, Tyers MB.
    Br J Pharmacol; 1990 Feb; 99(2):227-32. PubMed ID: 1691672
    [Abstract] [Full Text] [Related]

  • 6. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
    Costall B, Naylor RJ.
    Eur J Pharmacol; 1976 Nov; 40(1):9-19. PubMed ID: 791660
    [Abstract] [Full Text] [Related]

  • 7. The role of the mesolimbic dopaminergic system in the desipramine effect in the forced swimming test.
    Cervo L, Grignaschi G, Samanin R.
    Eur J Pharmacol; 1990 Mar 13; 178(1):129-33. PubMed ID: 2158897
    [Abstract] [Full Text] [Related]

  • 8. Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.
    Koulu M, Sjöholm B, Lappalainen J, Virtanen R.
    Eur J Pharmacol; 1989 Oct 10; 169(2-3):321-4. PubMed ID: 2530097
    [Abstract] [Full Text] [Related]

  • 9. Actions of ORG 5222 as a novel psychotropic agent.
    Costall B, Domeney AM, Kelly ME, Naylor RJ, Tomkins DM.
    Pharmacol Biochem Behav; 1990 Mar 10; 35(3):607-15. PubMed ID: 2111028
    [Abstract] [Full Text] [Related]

  • 10. The continuity of dopamine receptor antagonism can dictate the long-term behavioural consequences of a mesolimbic infusion of dopamine.
    Costall B, Domeney AM, Naylor RJ.
    Neuropharmacology; 1985 Mar 10; 24(3):193-7. PubMed ID: 3990920
    [Abstract] [Full Text] [Related]

  • 11. Ketotifen can antagonise changes in sensitivity of cerebral dopamine receptors: behavioural correlates in rodent and primate.
    Barnes JC, Barnes NJ, Barnes NM, Costall B, Domeney AM, Naylor RJ.
    Neuropharmacology; 1987 Jul 10; 26(7A):693-700. PubMed ID: 3114665
    [Abstract] [Full Text] [Related]

  • 12. Laterality of dopamine function and neuroleptic action in the amygdala in the rat.
    Bradbury AJ, Costall B, Domeney AM, Naylor RJ.
    Neuropharmacology; 1985 Dec 10; 24(12):1163-70. PubMed ID: 2869434
    [Abstract] [Full Text] [Related]

  • 13. Locomotor hyperactivity caused by dopamine infusion into the nucleus accumbens of rat brain: specificity of action.
    Costall B, Domeney AM, Naylor RJ.
    Psychopharmacology (Berl); 1984 Dec 10; 82(3):174-80. PubMed ID: 6144126
    [Abstract] [Full Text] [Related]

  • 14. Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain.
    Hagan RM, Butler A, Hill JM, Jordan CC, Ireland SJ, Tyers MB.
    Eur J Pharmacol; 1987 Jun 19; 138(2):303-5. PubMed ID: 2442006
    [No Abstract] [Full Text] [Related]

  • 15. Behavioural consequences of the infusion of dopamine into the nucleus accumbens of the common marmoset (Callithrix jacchus).
    Barnes NJ, Costall B, Domeney AM, Naylor RJ.
    Neuropharmacology; 1987 Sep 19; 26(9):1327-35. PubMed ID: 2890118
    [Abstract] [Full Text] [Related]

  • 16. Non-opiate beta-endorphin fragments and dopamine--VI. Behavioural analysis of the interaction between gamma-type endorphins and dopaminergic systems in the nucleus accumbens of rats.
    Király I, Van Ree JM.
    Neuropharmacology; 1984 May 19; 23(5):511-6. PubMed ID: 6204246
    [Abstract] [Full Text] [Related]

  • 17. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway.
    Crawley JN.
    J Neurosci; 1992 Sep 19; 12(9):3380-91. PubMed ID: 1527584
    [Abstract] [Full Text] [Related]

  • 18. Competitive NMDA receptor antagonists do not produce locomotor hyperactivity by a dopamine-dependent mechanism.
    Ouagazzal A, Amalric M.
    Eur J Pharmacol; 1995 Dec 27; 294(1):137-46. PubMed ID: 8788425
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the behavioural consequences of chronic stimulation of dopamine receptors in the nucleus accumbens of rat brain effected by a continuous infusion or by single daily injections.
    Costall B, Domeney AM, Naylor RJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep 27; 324(1):27-33. PubMed ID: 6633677
    [Abstract] [Full Text] [Related]

  • 20. Modulation of dopamine function by glycine in the nucleus accumbens of the brain of the rat.
    Barnes JC, Costall B, Naylor RJ.
    Neuropharmacology; 1986 Dec 27; 25(12):1347-51. PubMed ID: 3561713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.